Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Technology
  • Entertainment
  • Real Estate
  • Business
  • Software
  • Security
Washingtoner

Global Platelet Concentration Systems Market to surpass US$ 1,110.4 million by end of 2027, Says Coherent Market Insights (CMI)
Washingtoner/10099438

Trending...
  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • Sturtevant's Offers Free Ski and Snowboard Edge-and-Wax Services in Bellevue Oct. 29
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global platelet concentration systems market is estimated to be valued at US$ 286.99 million in 2020 and is expected to exhibit a CAGR of 21.2% during the forecast period (2020-2027).

Key Trends and Analysis:

The global platelet concentration systems market is expected to witness significant growth, owing to increasing launches of Platelet Rich Plasma systems. For instance, in 2014, Mitek Sports Medicine, a leader in orthopedics sports medicine and a part of the DePuy Synthes Companies of Johnson & Johnson, announced launch of PEAK Platelet Rich Plasma (PRP) System, a new device that produces high quality PRP in two and a half minutes.

Launches of PRP products and services is also expected to drive growth of the global platelet concentration systems market. For instance, in October 2013, The Global Stem Cells Group, Inc. announced the launch of Plasma Plus medical services in the Dominican Republic)

Furthermore, increasing geriatric population across the globe has increased the cases of orthopedic conditions and other medical problems that require plasma therapy, which is expected to drive the market growth. According to the United Nations (UN) 2019 report, there were around 703 million people globally aged 65 years and above in 2019, which is expected to reach 1.5 billion by 2050.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4324

Key Market Takeaways:


The global platelet concentration systems market is expected to exhibit a CAGR of 21.2% during the forecast period (2020-2027), as key players are focusing on facility expansion in order to expand their product portfolio. For instance, in October 2017, Arthrex Inc. built a new state-of-the-art surgical device and implant manufacturing facility in Anderson County, South Carolina. This investment is part of Arthrex's global expansion plan to support the development of new and innovative products that help surgeons treat their patients better.

More on Washingtoner
  • ThriveStack citedby launches Prompt Research to find the prompts buyers ask in AI search
  • New Finnish Affiliate Site Ilmaiskierrokset.com Puts Wager-Free Spins in the Spotlight
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Immerse Yourself in the Historic Tochigi Autumn Festival, Celebrated Every Two Years Since 1874
  • Tacoma: OMWBE Active Certification Class on November 16

Competitive Landscape:

Key players operating in the global platelet concentration systems market include Anthrax Inc., Stryker Corporation, Johnson & Johnson's, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4324

Market Segmentation:
  • Global Platelet Concentration Systems Market, By Technology:
    • Apheresis Technology
    • Single Spin Technology
    • Double Spin Technology
  • Global Platelet Concentration Systems Market, By End User:
    • Hospital
    • Orthopedic Clinics
    • Sports Injury Centers
    • Ambulatory Surgical Centers
  • Global Platelet Concentration Systems Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Country:
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Reports:

More on Washingtoner
  • Ornamental Designer Pro to Attend METALfab 2027, Sponsor Wednesday Opening Reception
  • The Case For Civil Disagreement
  • Resident Inspect Expands Virtual Property Inspections With AppFolio and Rentvine Integrations
  • Unlocking the Next Phase of Growth with New AI Innovations; Targeting 2027 as Breakeven; Revenue Momentum Accelerates: ZenaTech (N A S D A Q: ZENA)
  • AeroNet Deploys netElastic vBNG and CGNAT with Tarana Wireless to Deliver Scalable, Fiber-Class Broadband Across Puerto Rico

Plasma Therapy Market, By Type (Pure PRP, Leucocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), and Leukocyte-rich Fibrin (L-PRF)), By Application (Infections Diseases, Dental, Nerve Injury, Cardiac Muscle Injury, and Other Applications), By End-User (Hospitals & Clinics, Research Institutes, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/plasma-therapy-market-4155

Europe Platelet rich Plasma Market, By Product Type (Instruments, Kits (Kit By Type (Pure Platelet-Rich Plasma (P-PRP), Leukocyte-Rich Platelet-Rich Plasma (L-PRP), Leukocyte-Platelet-Rich Fibrin (L-PRF), Pure Platelet-Rich Fibrin (P-PRF)),Kit By Origin (Autologous Platelet-Rich Plasma, Homologus Platelet-Rich Plasma, Allogeneic Platelet-Rich Plasma))), By Application (Knee, Elbow, Foot and Ankle, Shoulder, CMF, Others) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/europe-platelet-rich-plasma-market-3346

About Us:

Coherent Market Insights
is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Paraguay Expedition Offers a Different View of Human Resilience
  • Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
  • Datavalet Named One of Quebec's Best Workplaces™ for 2026
  • Phinge Corporation Engages Sheridan Ross PC for Certain Intellectual Property Matters
  • Alan Hamilton of Shiver Hamilton Campbell Inducted as a Fellow of the American College of Trial Lawyers
  • Slotozilla Hosts Exclusive Halloween Casino Bonuses for 2026
  • Remcon Equipment Marks 35 Years as a Conveyor Company, With 1,500+ Systems Built
  • "BROOKLYN, BROOKLYN, BROOKLYN" children's book and official YouTube channel launch on October 27th
  • Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
  • Nextlink Internet Deploys netElastic to Modernize Its Hybrid Broadband Network
  • Dynamic Relaunch as AI Predictive Cybersecurity Company Optimized to Prevent Threats Proactively: Cycurion, Inc. (N A S D A Q: CYCU)
  • EMBER™ Unveils the Workplace Identity Score™ (WIS™), the First Standard for Measuring Workplace Impact on Workforce Performance & Business Growth
  • With Oil Prices Surging…Sky Quarry's Nevada Refinery Is Back in Action — CEO Highlights a Powerful New Growth Chapter for (N A S D A Q: SKYQ)
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Win Gold in Raleigh's Best Awards for Second Consecutive Year
  • We are Talker Study: 64% of AI Users Have Bought From a Brand AI Introduced, as The Invisible Shortlist Reshapes Brand Discovery
  • One in three Americans may have lost track of retirement savings from a previous job
  • Political Concerns Drive US Investors to Golden Visas
  • Tacoma: T-Town Takes Over the Dome Oct. 30
  • New Book Savvy Not Sabotaged Helps Those Hurt by Betrayal Set Boundaries Without Shutting Others Out
  • CPPS to Host Webinar on the Revised ASIS Workplace Violence Prevention and Intervention Standard
_catLbl0 _catLbl1

Popular on Washingtoner

  • ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains - 324
  • CinderLabs Launches AI Agent Marketplace: Nine Pre-Built Agents for Regulated Industries - 245
  • Spokane: City and Permittable Partner to Support Rebuilding After Wildfires - 227
  • City of Tacoma Invites Community Members to Share Their Experience Crossing I-5 - 223
  • Spokane: City to provide asbestos testing, host community resource meetings - 182
  • Tacoma: In-Person Workshop on October 22 for Local Businesses on the City’s Revolving Loan Fund Process - 157
  • Tacoma: Homicide Investigation – 800 Pacific Avenue - 145
  • City of Tacoma Awarded Competitive State Grant to Evaluate Residential Development Regulations and Permit Processing Times - 126
  • Georgia's Magical Nights of Lights Bigger and Brighter for 2026 - 112
  • Final Week to Register for Free Spokane Community Conference - 105

Similar on Washingtoner

  • Steve Weclew is Appointed by STS Capital Partners as Managing Director
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Unlocking the Next Phase of Growth with New AI Innovations; Targeting 2027 as Breakeven; Revenue Momentum Accelerates: ZenaTech (N A S D A Q: ZENA)
  • New Atlas Maps the 38 States Behind Every Conversation
  • NECP Promotes Chertova to Senior Business Analyst
  • Security Industry Veteran Anthony Rumore Launches AegisLead to Help Security Companies Find Business and Manage Growth
  • Canadian Woman Plants 1,667 Love Stories in a Field of Peonies That Could Bloom for 100 Years
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • Access Control Security Shares 5 Ways Retailers Can Prevent Holiday Theft
  • Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute